Lonza Group(LONN.SW)
Lonza Group AG (Visp, Switzerland; SIX: LONN; ~CHF 6.7B revenue) is the world's largest pharmaceutical and biotech CDMO (Contract Development and Manufacturing Organization). Primary business is biologic drug manufacturing (mammalian cell culture, microbial fermentation) for pharma clients. Manufactured Moderna COVID-19 mRNA. Sold Specialty Ingredients (biocides: benzalkonium chloride, quats) to Arxada in 2021. Capsules and health ingredients division (HPMC and gelatin capsules) is the world's largest hard capsule manufacturer.